Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Albin

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2024
Salience network segregation mediates the effect of tau pathology on mild behavioral impairmentAlexandru D Iordan, Robert Ploutz-Snyder, Bidisha Ghosh, et al.
Plos One|July 14, 2012
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyIrene M Lelieveld, Martijn L T M Müller, Nicolaas I Bohnen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 17, 2015
Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic reviewMyria Petrou, Ben A Dwamena, Bradley R Foerster, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Salience Network Segregation Mediates the Effect of Tau Pathology on Mild Behavioral ImpairmentAlexandru D Iordan, Robert Ploutz-Snyder, Bidisha Ghosh, et al.
Frontiers in Chemistry|April 18, 2022
Automated Synthesis of <sup>18</sup>F-BCPP-EF {2-<i>tert</i>-Butyl-4-Chloro-5-{6-[2-(2[<sup>18</sup>F]fluoroethoxy)-Ethoxy]-Pyridin-3-ylmethoxy}-2<i>H</i>-Pyridazin-3-One for Imaging of Mitochondrial Complex 1 in Parkinson's DiseaseTanpreet Kaur, Allen F Brooks, Katherine M Liddell, et al.
Human Molecular Genetics|June 19, 2010
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's diseaseGiselle M Perry, Sara Tallaksen-Greene, Ashish Kumar, et al.
Molecular & Cellular Proteomics : MCP|July 24, 2007
Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometerSheng Pan, Min Shi, Jinghua Jin, et al.
Annals of Neurology|February 6, 2019
Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseNicolaas I Bohnen, Prabesh Kanel, Zhi Zhou, et al.
Molecular Pharmaceutics|March 15, 2022
No Dopamine Agonist Modulation of Brain [<sup>18</sup>F]FEOBV Binding in Parkinson's DiseaseRoger L Albin, Prabesh Kanel, Teus van Laar, et al.
Brain Communications|September 10, 2024
Dynamic balance and gait impairments in Parkinson's disease: novel cholinergic patternsNicolaas I Bohnen, Uros Marusic, Stiven Roytman, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2024
Salience network segregation mediates the effect of tau pathology on mild behavioral impairmentAlexandru D Iordan, Robert Ploutz-Snyder, Bidisha Ghosh, et al.
Plos One|July 14, 2012
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyIrene M Lelieveld, Martijn L T M Müller, Nicolaas I Bohnen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 17, 2015
Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic reviewMyria Petrou, Ben A Dwamena, Bradley R Foerster, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Salience Network Segregation Mediates the Effect of Tau Pathology on Mild Behavioral ImpairmentAlexandru D Iordan, Robert Ploutz-Snyder, Bidisha Ghosh, et al.
Frontiers in Chemistry|April 18, 2022
Automated Synthesis of <sup>18</sup>F-BCPP-EF {2-<i>tert</i>-Butyl-4-Chloro-5-{6-[2-(2[<sup>18</sup>F]fluoroethoxy)-Ethoxy]-Pyridin-3-ylmethoxy}-2<i>H</i>-Pyridazin-3-One for Imaging of Mitochondrial Complex 1 in Parkinson's DiseaseTanpreet Kaur, Allen F Brooks, Katherine M Liddell, et al.
Human Molecular Genetics|June 19, 2010
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's diseaseGiselle M Perry, Sara Tallaksen-Greene, Ashish Kumar, et al.
Molecular & Cellular Proteomics : MCP|July 24, 2007
Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometerSheng Pan, Min Shi, Jinghua Jin, et al.
Annals of Neurology|February 6, 2019
Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseNicolaas I Bohnen, Prabesh Kanel, Zhi Zhou, et al.
Molecular Pharmaceutics|March 15, 2022
No Dopamine Agonist Modulation of Brain [<sup>18</sup>F]FEOBV Binding in Parkinson's DiseaseRoger L Albin, Prabesh Kanel, Teus van Laar, et al.
Brain Communications|September 10, 2024
Dynamic balance and gait impairments in Parkinson's disease: novel cholinergic patternsNicolaas I Bohnen, Uros Marusic, Stiven Roytman, et al.
Pageof 25